Vinay Prasad
Vinayak K. Prasad (born 1982) is an American hematologist-oncologist. He is an associate professor of medicine at the Oregon Health & Science University School of Medicine. Prasad is a noted critic on the direction of cancer research. He has developed a following using Twitter as his platform. He is also the author of multiple books, including "Ending Medical Reversal" (2015) [1], co-authored with Dr. Adam Cifu and "Malignant: How Bad Evidence and Bad Policy Harm People With Cancer" to be released in Spring 2020.
Vinay Prasad | |
---|---|
Born | Vinayak K. Prasad 1982 (age 37–38) |
Alma mater | Michigan State University (BA) University of Chicago (MD) Johns Hopkins University (MPH) |
Scientific career | |
Fields | Hematology, oncology |
Institutions | Oregon Health & Science University |
Website | vinayakkprasad |
Early life and education
Vinay Prasad was raised in a suburb of Cleveland, Ohio before moving outside of Chicago in northern Indiana. His parents immigrated from India. Prasad has a younger brother.[2]
He graduated from high school with straight As and was one of the 16 valedictorians. Prasad attended Michigan State University where he took courses in health care ethics and physiology. He did not initially intend to become a physician, and took the Medical College Admission Test after his roommate suggested it. In 2005, Prasad graduated summa cum laude from MSU with a double major in Philosophy and Physiology.[2] He completed his medical degree at University of Chicago in 2009 and completed a residency in internal medicine at Northwestern University in 2012. In 2012, Prasad was certified in internal medicine by the American Board of Internal Medicine. In 2014, he earned a Master's of Public Health from Johns Hopkins University. In 2015, Prasad held a fellowship in oncology at the National Cancer Institute and hematology at the National Heart, Lung, and Blood Institute.[3]
Career
Prasad is a hematologist-oncologist at the Oregon Health & Science University. He is part of the lymphoma team that treats patients with hematologic malignancies. Prasad is also an assistant professor of medicine.[3] He is a noted critic on the direction of cancer research. Prasad has developed a following using Twitter and his podcast "Plenary Session". [4][5] He also studies the financial conflicts in drug approvals.[6] Prasad is a member of the American Society of Clinical Oncology.[3]
Selected works
Articles
- Prasad, Vinay; Cifu, Adam; Ioannidis, John P. A. (January 4, 2012). "Reversals of Established Medical Practices". JAMA. 307 (1): 37–8. doi:10.1001/jama.2011.1960. PMID 22215160.
- Prasad, Vinay; Vandross, Andrae; Toomey, Caitlin; Cheung, Michael; Rho, Jason; Quinn, Steven; Chacko, Satish Jacob; Borkar, Durga; Gall, Victor (2013). "A Decade of Reversal: An Analysis of 146 Contradicted Medical Practices". Mayo Clinic Proceedings. 88 (8): 790–798. doi:10.1016/j.mayocp.2013.05.012. PMID 23871230.
- Prasad, Vinay (2016). "Perspective: The precision-oncology illusion". Nature. 537 (7619): S63. doi:10.1038/537S63a. PMID 27602743.
Books
- Prasad, Vinayak K.; Cifu, Adam S. (2015). Ending Medical Reversal: Improving Outcomes, Saving Lives. JHU Press. ISBN 9781421417721.[7]
References
- Zuger, Abigail (October 30, 2015). "Book Review: 'Ending Medical Reversal' Laments Flip-Flopping". NYT. Retrieved December 4, 2019.
- Terry, Lynne (September 7, 2017). "Dr. Vinay Prasad, OHSU's iconoclastic oncologist, calls out shoddy medicine". Oregon Live. The Oregonian. Retrieved July 11, 2018.
- "Vinay Prasad, MD, MPH | OHSU People". Oregon Health & Science University. Retrieved July 11, 2018.
- Harris, Richard (June 24, 2018). "Tweeting Oncologist Draws Ire And Admiration For Calling Out Hype". NPR. Retrieved July 11, 2018.
- Hayes, Elizabeth (April 5, 2017). "OHSU's Vinay Prasad on being the medical field's willing provocateur". Portland Business Journal. Retrieved July 11, 2018.
- Piller, Charles (July 6, 2018). "Hidden conflicts?". Science. 361 (6397): 16–20. doi:10.1126/science.361.6397.16. ISSN 0036-8075. PMID 29976808.
- Reviews of Ending Medical Reversal: Improving Outcomes, Saving Lives:
- Chokshi, Dave A. (2016). "A course in reversal". The Lancet. 387 (10025): 1266. doi:10.1016/s0140-6736(16)30025-3. ISSN 0140-6736.
- Zuger, Abigail (October 30, 2015). "Book Review: 'Ending Medical Reversal' Laments Flip-Flopping". New York Times. Retrieved July 11, 2018.
- Grossman, S. C. (March 2016). "Review". Choice. 53 (7): 1047–1048 – via ProQuest.